APA (7th ed.) Citation

A, S., BR, S., R, C., L, P., A, V., N, B. N., . . . Y, Y. (2026). TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens. EMBO molecular medicine, 18(6), 2062. https://doi.org/10.1038/s44321-026-00423-7

Chicago Style (17th ed.) Citation

A, Sekar, et al. "TMPRSS2-ERG Confers Resistance of Prostate Cancer to Antiandrogens." EMBO Molecular Medicine 18, no. 6 (2026): 2062. https://doi.org/10.1038/s44321-026-00423-7.

MLA (9th ed.) Citation

A, Sekar, et al. "TMPRSS2-ERG Confers Resistance of Prostate Cancer to Antiandrogens." EMBO Molecular Medicine, vol. 18, no. 6, 2026, p. 2062, https://doi.org/10.1038/s44321-026-00423-7.